Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 525 of 1467 entries
View as:

A PK Comparability Study of Two Different Amlitelimab Drug Products in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05796479 Org: User:
Start: 04/28/22 End: 05/22/23 Due: 05/22/24

Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02812706 Org: User:
Start: 09/05/16 End: 09/28/22 Due: 09/28/23

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT03510884 Org: User:
Start: 05/31/18 End: 08/05/22 Due: 08/05/23

Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid

Phase: N/A Priority: Normal
NCT ID: NCT00174733 Org: User:
Start: 07/31/05 End: 02/28/06 Due: 02/28/07

A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01033123 Org: User:
Start: 12/31/09 End: 02/29/12 Due: 02/28/13

Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01625494 Org: User:
Start: 05/31/12 End: 01/31/13 Due: 01/31/14

Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04)

Phase: N/A Priority: Normal
NCT ID: NCT04394624 Org: User:
Start: 08/31/20 End: 10/24/24 Due: 10/24/25

Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00358124 Org: User:
Start: 01/31/01 End: 06/30/02 Due: 06/30/03

Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03324113 Org: User:
Start: 10/17/17 End: 12/26/22 Due: 12/26/23

Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion

Phase: N/A Priority: Normal
NCT ID: NCT01551069 Org: User:
Start: 03/31/12 End: 04/30/14 Due: 04/30/15

Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin

Phase: N/A Priority: Normal
NCT ID: NCT05819125 Org: User:
Start: 04/25/23 End: 12/15/23 Due: 12/15/24

Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT05588843 Org: User:
Start: 11/25/22 End: 12/16/26 Due: 12/16/27

A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01034995 Org: User:
Start: 02/28/10 End: 03/31/11 Due: 03/31/12

Insulin Glargine in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00268645 Org: User:
Start: 09/30/04 End: - Due: -

Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00685958 Org: User:
Start: 07/31/06 End: 03/31/07 Due: 03/31/08

Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00529750 Org: User:
Start: 07/31/02 End: 01/31/05 Due: 01/31/06

Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT06907511 Org: User:
Start: 04/17/25 End: 05/28/26 Due: 05/28/27

Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)

Phase: N/A Priority: Normal
NCT ID: NCT07038473 Org: User:
Start: 07/18/25 End: 07/31/26 Due: 07/31/27

Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial

Phase: N/A Priority: Normal
NCT ID: NCT00851903 Org: User:
Start: 06/30/09 End: 09/30/11 Due: 09/30/12

A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT02977533 Org: User:
Start: 12/01/16 End: 05/16/18 Due: 05/16/19

Irbesartan in Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00265967 Org: User:
Start: 09/30/05 End: - Due: -

Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients

Phase: N/A Priority: Normal
NCT ID: NCT02401243 Org: User:
Start: 03/31/15 End: 02/29/16 Due: 02/28/17

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05552859 Org: User:
Start: 12/05/22 End: 08/04/23 Due: 08/04/24

Taxotere + Cisplatin in Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00436293 Org: User:
Start: 12/31/02 End: 03/31/10 Due: 03/31/11

Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers

Phase: N/A Priority: Normal
NCT ID: NCT01135017 Org: User:
Start: 07/31/10 End: 02/29/12 Due: 02/28/13